Atlas Capital Advisors’s Bausch Health BHC Stock Holding History

Atlas Capital Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-850	Closed	-$7.11K	–	923
2022 Q2	$7.11K	Hold	850	–	–	﹤0.01%	798
2022 Q1	$19.4K	Hold	850	–	–	﹤0.01%	641
2021 Q4	$23.5K	Hold	850	–	–	﹤0.01%	620
2021 Q3	$23.7K	Hold	850	–	–	﹤0.01%	621
2021 Q2	$24.9K	Hold	850	–	–	﹤0.01%	626
2021 Q1	$27K	Buy	+850	New	+$24.9K	0.01%	559
2020 Q1	–	Sell	-7,270	Closed	-$218K	–	661
2019 Q4	$218K	Hold	7,270	–	–	0.05%	307
2019 Q3	$159K	Hold	7,270	–	–	0.05%	351
2019 Q2	$183K	Hold	7,270	–	–	0.06%	303
2019 Q1	$180K	Hold	7,270	–	–	0.06%	277
2018 Q4	$134K	Hold	7,270	–	–	0.05%	307
2018 Q3	$206K	Buy	+7,270	New	+$166K	0.07%	283
2018 Q2	–	Sell	-7,270	Closed	-$116K	–	510
2018 Q1	$116K	Buy	+7,270	New	+$135K	0.04%	327

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Atlas Capital Advisors's BHC Position: Q3 2022 in Review

Atlas Capital Advisors sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 850 shares — an estimated $7.11K sold.

Atlas Capital Advisors first reported a position in BHC in Q1 2018 and held it in 13 quarters. The position peaked at $218K in Q4 2019. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

Atlas Capital Advisors reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
Atlas Capital Advisors sold 850 Bausch Health shares in Q3 2022, an estimated $7.11K.
Atlas Capital Advisors first reported a position in Bausch Health in Q1 2018 and held it in 13 quarters.
Atlas Capital Advisors's Bausch Health position peaked at $218K in Q4 2019.
283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Atlas Capital Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.